Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001140361-25-002892
Filing Date
2025-02-03
Accepted
2025-02-03 16:40:58
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 ny20042511x5_424b5.htm 424B5 740430
2 logo_ghresearch1.jpg GRAPHIC 69060
3 logo_ghresearch.jpg GRAPHIC 33581
4 ny20042511x5_linegraph0x1.jpg GRAPHIC 235475
5 ny20042511x5_table01x1.jpg GRAPHIC 361472
6 ny20042511x5_table02x1.jpg GRAPHIC 348476
  Complete submission text file 0001140361-25-002892.txt   2183969
Mailing Address JOSHUA DAWSON HOUSE DAWSON STREET DUBLIN 2 L2 D02 RY95
Business Address JOSHUA DAWSON HOUSE DAWSON STREET DUBLIN 2 L2 D02 RY95 353 1 437 8334
GH Research PLC (Filer) CIK: 0001855129 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-270418 | Film No.: 25583178
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)